Pasche B, Ouimet H, Francis S, Loscalzo J
Cardiology Divisions, Brigham and Women's Hospital, Boston, MA 02115.
Blood. 1994 Jan 15;83(2):404-14.
Plasmin exposure modulates platelet aggregation responses, but a direct effect of plasmin on the platelet fibrinogen receptor, glycoprotein IIb/IIIa (GPIIb/IIIa), has never been conclusively shown in a plasma milieu. To examine this issue, we incubated platelets in platelet-rich plasma with plasmin and measured the effect of this treatment on platelet aggregation, fibrinogen binding, and the structural integrity of GPIIb/IIIa. Plasmin treatment reduced maximal reversible fibrinogen binding in a dose-dependent fashion, and this reduction in binding was accompanied by a correlative reduction in the maximal rate of aggregation. Immunoblots performed with polyclonal antibodies against GPIIb/IIIa showed that GPIIIa had been cleaved by plasmin, but this cleavage was detected only after subsequent degradation of the solubilized GPIIb/IIIa with Staphylococcus aureus V8 (Glu-C) endoprotease. Peptide sequence analysis showed that cleavage occurred at the lys444-pro445 bond in the first cysteine-rich repeat domain of GPIIIa a unique proteolytic event observed only in the presence of plasma fibrinogen. These observations suggest that plasmin modifies GPIIIa by a unique proteolytic event in plasma that is dependent on fibrinogen binding and, consequently, is accompanied by significant reductions in fibrinogen binding and aggregation response.
纤溶酶的暴露可调节血小板聚集反应,但在血浆环境中,纤溶酶对血小板纤维蛋白原受体糖蛋白IIb/IIIa(GPIIb/IIIa)的直接作用从未得到确凿证实。为研究此问题,我们将血小板置于富含血小板的血浆中与纤溶酶共同孵育,并检测该处理对血小板聚集、纤维蛋白原结合以及GPIIb/IIIa结构完整性的影响。纤溶酶处理以剂量依赖方式降低了最大可逆性纤维蛋白原结合,且这种结合的降低伴随着聚集最大速率的相应降低。用抗GPIIb/IIIa多克隆抗体进行的免疫印迹显示,GPIIIa已被纤溶酶切割,但这种切割仅在随后用金黄色葡萄球菌V8(Glu-C)内切蛋白酶对溶解的GPIIb/IIIa进行降解后才能检测到。肽序列分析表明,切割发生在GPIIIa第一个富含半胱氨酸重复结构域的lys444-pro445键处,这是仅在血浆纤维蛋白原存在时才观察到的独特蛋白水解事件。这些观察结果表明,纤溶酶通过血浆中一种独特的蛋白水解事件修饰GPIIIa,该事件依赖于纤维蛋白原结合,因此伴随着纤维蛋白原结合和聚集反应的显著降低。